- 专利标题： CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF
-
申请号： US15235572申请日： 2016-08-12
-
公开(公告)号： US20160368902A1公开(公告)日： 2016-12-22
- 发明人: John BURNIER , Thomas GADEK , Frederic NAUD
- 申请人： SARCODE BIOSCIENCE INC.
- 申请人地址： US CA Brisbane
- 专利权人： SARCODE BIOSCIENCE INC.
- 当前专利权人： SARCODE BIOSCIENCE INC.
- 当前专利权人地址： US CA Brisbane
- 主分类号： C07D405/06
- IPC分类号： C07D405/06 ; A61K45/06 ; A61K9/06 ; A61K9/08 ; A61K47/22 ; A61K47/10 ; A61K47/14 ; A61K47/38 ; A61K47/06 ; A61K47/18 ; A61K47/02 ; C07D217/04 ; C07D217/02 ; C07C317/48 ; A61K31/4725
摘要：
Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.
公开/授权文献
信息查询
